NJ High Court Won't Disturb Novartis Bone Drug Win
The New Jersey Supreme Court has declined to hear a challenge to judgments for Novartis Pharmaceuticals Corp. in the first bellwether trial in consolidated litigation over claims the drugmaker's bone cancer...To view the full article, register now.
Already a subscriber? Click here to view full article